Park, S., Kelaidi, C., Meunier, M., Casadevall, N., Gerds, A. T., & Platzbecker, U. (2019). The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: A review of the literature and expert opinion. Ann Hematol.
Citação norma ChicagoPark, Sophie, Charikleia Kelaidi, Mathieu Meunier, Nicole Casadevall, Aaron T. Gerds, and Uwe Platzbecker. "The Prognostic Value of Serum Erythropoietin in Patients With Lower-risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion." Ann Hematol 2019.
Citação norma MLAPark, Sophie, et al. "The Prognostic Value of Serum Erythropoietin in Patients With Lower-risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion." Ann Hematol 2019.